Cormorant Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $9.97M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $8.55M | Sell |
|
|||||
|
2016
Q2 | $11.1M | Sell |
|
|||||
|
2016
Q1 | $15.4M | Hold |
|
|||||
|
2015
Q4 | $23.1M | Buy |
|
|||||
|
2015
Q3 | $11.3M | Hold |
|
|||||
|
2015
Q2 | $16.8M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $3.9M | Hold |
|
|||||
|
2014
Q2 | $3.16M | Hold |
|
|||||
|
2014
Q1 | $3.36M | Sell |
|
|||||
|
2013
Q4 | $16.1M | Buy |
|